ALS: A Disease of Motor Neurons and Their Nonneuronal Neighbors

  title={ALS: A Disease of Motor Neurons and Their Nonneuronal Neighbors},
  author={S{\'e}verine Boill{\'e}e and Christine Vande Velde and Don W. Cleveland},

Figures and Tables from this paper

Amyotrophic lateral sclerosis: from current developments in the laboratory to clinical implications.

The clinical implication of these findings is that promising therapeutic approaches can be derived from multidrug treatments aimed at the simultaneous interception of damage in both motor neurons and nonmotor neuronal cells.

Astrocytes from Familial and Sporadic ALS Patients are Toxic to Motor Neurons

It is demonstrated that astrocytes derived from postmortem tissue from both FALS and SALS patients are similarly toxic to motor neurons and that SOD1 is a viable target for SALS, as its knockdown significantly attenuatesAstrocyte-mediated toxicity toward motor neurons.

Rodent Models of Amyotrophic Lateral Sclerosis

Amyotrophic Lateral Sclerosis (ALS) is a motor neuron disease affecting upper and lower motor neurons in the central nervous system. Patients with ALS develop extensive muscle wasting and atrophy

Current hypotheses for the underlying biology of amyotrophic lateral sclerosis

It is demonstrated that mutations and pathology associated with the TDP‐43 gene and protein may be more common than SOD1 mutations in familial and sporadic ALS, and Convergence of these pathways is likely to mediate disease onset and progression.

Microglia centered pathogenesis in ALS: insights in cell interconnectivity

Insights into the complex intercellular perturbations underlying ALS, including target identification, will enhance efforts to develop effective therapeutic approaches for preventing or reversing symptomatic progression of this devastating disease.

Astrocytic protection of spinal motor neurons but not cortical neurons against loss of Als2/alsin function.

It is demonstrated that alsin-depleted spinal motor neurons can be rescued from defective survival and axon growth by co-cultured astrocytes, the first example of non-cell-autonomous glial effects in a recessive form of motor neuron disease.

Protective and Toxic Neuroinflammation in Amyotrophic Lateral Sclerosis

This review will focus on the cellular players involved in neuroinflammation in ALS and current therapeutic strategies to enhance neuroprotection and suppress neurotoxicity with the goal of arresting the progressive and devastating nature of ALS.

Molecular and Cellular Mechanisms Affected in ALS

A cohesive understanding of the molecular functions of ALS-associated genes may provide clues to common molecular mechanisms across both familial (inherited) and sporadic cases and could be key to the development of effective therapeutic approaches.

Amyotrophic Lateral Sclerosis: A Neurodegenerative Motor Neuron Disease With Ocular Involvement

The current review discusses the main aspects related to ALS, such as the main genes involved, the most important molecular mechanisms that affect this pathology, its ocular involvement, and the possible usefulness of the retina as a biomarker.



Onset and Progression in Inherited ALS Determined by Motor Neurons and Microglia

Onset and progression of amyotrophic lateral sclerosis represent distinct disease phases defined by mutant action within different cell types to generate non–cell-autonomous killing of motor neurons; these findings validate therapies, including cell replacement, targeted to the non-neuronal cells.

Massive Mitochondrial Degeneration in Motor Neurons Triggers the Onset of Amyotrophic Lateral Sclerosis in Mice Expressing a Mutant SOD1

The absence of massive motor neuron death at the early stages of the disease indicates that the majority of motor neurons could be rescued after clinical diagnosis, and indicates that mutant SOD1 toxicity is mediated by damage to mitochondria in motor neurons.

Absence of neurofilaments reduces the selective vulnerability of motor neurons and slows disease caused by a familial amyotrophic lateral sclerosis-linked superoxide dismutase 1 mutant.

By deleting NF-L, the major neurofilament subunit required for filament assembly, onset and progression of disease caused by familial ALS-linked SOD1 mutant G85R are significantly slowed, while selectivity of mutant-mediated toxicity for motor neurons is reduced.

Slowing of axonal transport is a very early event in the toxicity of ALS–linked SOD1 mutants to motor neurons

Reduced transport of selective cargoes of slow transport, especially tubulin, arises months before neurodegeneration in two SOD1 mutations linked to familial ALS, verifying the hypothesis that damage to the cargoe or machinery ofslow transport is an early feature of toxicity mediated by mutant SOD 1.

Mutant SOD1 alters the motor neuronal transcriptome: implications for familial ALS.

Evidence is provided that dysregulation of Nrf2 and the ARE, coupled with reduced pentose phosphate pathway activity and decreased generation of NADPH, represent significant and hitherto unrecognized components of the toxic gain of function of mutant SOD1.

The neuroprotective factor Wlds does not attenuate mutant SOD1-mediated motor neuron disease

Despite its effectiveness in delaying axonal loss in other neurodegenerative models, the presence of Wlds did not slow disease onset, ameliorate mutant motor neuron death, axonal degeneration, or preserve synaptic attachments in mice that develop disease from ALS-linked S OD1 mutants SOD1G37R or SOD 1G85R.

Increased cytotoxic potential of microglia from ALS‐transgenic mice

It is found that mtSOD1 expression increases the production of TNF‐α and attenuates IL‐6‐release by LPS‐activated adult microglia, and suggests an increased cytotoxic potential of adult mtS OD1 microGLia, which only becomes apparent after microglial activation.